Your browser doesn't support javascript.
loading
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft.
Passeri, Thibault; Dahmani, Ahmed; Masliah-Planchon, Julien; Naguez, Adnan; Michou, Marine; El Botty, Rania; Vacher, Sophie; Bouarich, Rachida; Nicolas, André; Polivka, Marc; Franck, Coralie; Schnitzler, Anne; Némati, Fariba; Roman-Roman, Sergio; Bourdeaut, Franck; Adle-Biassette, Homa; Mammar, Hamid; Froelich, Sébastien; Bièche, Ivan; Decaudin, Didier.
Afiliación
  • Passeri T; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Dahmani A; Department of Genetics, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Masliah-Planchon J; Department of Neurosurgery, Lariboisière Hospital, Assistance Publique des Hôpitaux de Paris, University of Paris, 75010 Paris, France.
  • Naguez A; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Michou M; Department of Genetics, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • El Botty R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Vacher S; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Bouarich R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Nicolas A; Department of Genetics, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Polivka M; Integrated Cancer Research Site, Institut Curie, 75005 Paris, France.
  • Franck C; Department of Tumor Biology, Institut Curie, 75005 Paris, France.
  • Schnitzler A; Department of Pathology, Lariboisière Hospital, Assistance Publique des Hôpitaux de Paris, University of Paris, UMR 1141 Inserm, 75010 Paris, France.
  • Némati F; Department of Genetics, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Roman-Roman S; Department of Genetics, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Bourdeaut F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Adle-Biassette H; Department of Translational Research, Institut Curie, University of Paris Saclay, 75005 Paris, France.
  • Mammar H; Integrated Cancer Research Site, Institut Curie, 75005 Paris, France.
  • Froelich S; Department of Pathology, Lariboisière Hospital, Assistance Publique des Hôpitaux de Paris, University of Paris, UMR 1141 Inserm, 75010 Paris, France.
  • Bièche I; Proton Therapy Center, Institut Curie, 91400 Orsay, France.
  • Decaudin D; Department of Neurosurgery, Lariboisière Hospital, Assistance Publique des Hôpitaux de Paris, University of Paris, 75010 Paris, France.
Cancers (Basel) ; 14(6)2022 Mar 14.
Article en En | MEDLINE | ID: mdl-35326637
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza